SANUWAVE Health Q3 revenue falls on regulatory uncertainity, lower Ultramist system sales
Overview
Wound care products provider's Q3 revenue fell 24% yr/yr
Company posted Q3 operating loss, compared to operating income last year
Company says revenue decline driven by regulatory uncertainty and lower Ultramist system sales
Outlook
Sanuwave Health did not provide specific financial guidance
Result Drivers
REGULATORY UNCERTAINTY - Co said CMS proposed rule led to customer exits and reduced demand, especially among rural home care providers
USED EQUIPMENT MARKET - Co said secondary market for used Ultramist systems and uncertainty over 97610 code changes weighed on new system sales
CONSUMABLE SALES - Co reported slight increase in Ultramist applicator revenue despite overall sales decline
Company press release:
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Revenue | $8.60 mln | ||
Q3 Net Loss | $1.41 mln | ||
Q3 Gross Margin | 77.30% | ||
Q3 Operating Income | -$1.07 mln |
Reuters Recommended Reads
Nov 9 - Surgery Partners Inc Q3 revenue misses estimates
Nov 9 - US FDA orders new eye risk warnings for Ozempic, Zepbound
Nov 10 - TELA Bio Q3 revenue misses analyst estimates on lower OviTex PRS volumes
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)